Roa Pia-Allison, Hennessy John, Akcasu Nora, Levy Phillip D, Twiner Michael J
Integrated Biosciences Building (IBio), Wayne Health, Population Health, 6135 Woodward Ave, Detroit, MI, USA.
Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA.
Curr Hypertens Rep. 2025 Jan 15;27(1):6. doi: 10.1007/s11906-025-01324-9.
To review the most current recommendations regarding assessment and treatment of asymptomatic hypertension treatment in the emergency department (ED) and to provide guidance for prescribing oral antihypertensive therapy for ED providers.
There are varying management strategies for the treatment of asymptomatic hypertension in the ED likely due to a lack of direct guidelines for treatment. There is an increasing body of evidence for the safety of initiating therapy to treat chronic asymptomatic hypertension in the ED. Initiation and optimization of oral antihypertensive therapy in indicated patients can be done by ED providers to enhance and expediate transition of care for patients and can ultimately aid in prevention of cardiovascular disease (CVD). This review provides guidance of when oral antihypertensive therapy can be initiated, medication options depending on the patient's blood pressure and other concurrent medications (if applicable), as well as other factors that may influence choice of therapy are described. Oral antihypertensive therapies can be initiated and optimized in the ED for patients with asymptomatic chronic hypertension.
回顾急诊科（ED）无症状高血压评估与治疗的最新建议，并为ED医护人员开具口服抗高血压治疗药物提供指导。
由于缺乏直接的治疗指南，ED中无症状高血压的治疗存在多种管理策略。越来越多的证据表明在ED中启动治疗慢性无症状高血压的安全性。ED医护人员可对符合指征的患者启动并优化口服抗高血压治疗，以加强和加快患者的护理过渡，并最终有助于预防心血管疾病（CVD）。本综述提供了何时可启动口服抗高血压治疗的指导，根据患者血压及其他同时服用的药物（如适用）选择药物，以及描述了可能影响治疗选择的其他因素。对于无症状慢性高血压患者，可在ED中启动并优化口服抗高血压治疗。
